The G9a protein content is higher in NB cell lines with MYCN amplification and in poorly differentiated or undifferentiated NB tumors, and G9a expression correlates with the expression of EZH2, which is a known oncoprotein in NB. The gene discussed is EZH2; the disease is neuroblastoma.